Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of -486.44% is 1469% below its 5-year average of 35.54%, near the low end of its 5-year range (-745.77%–725.04%).
502.05% below its 12-month average of 120.99%.
Reported quarterly gross margin; no daily interpolation. Q3 FY2026 (2026-06-30): -302.64%.
GROSS MARGIN
-486.44%
GROSS MARGIN AVG TTM
120.99%
GROSS MARGIN AVG 3Y
51.45%
GROSS MARGIN AVG 5Y
35.54%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-502.05%
CURRENT VS 3Y AVG
-1045.44%
CURRENT VS 5Y AVG
-1468.90%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
40.63%
median of 784 covered companies
CURRENT VS SECTOR MEDIAN
-1297.24%
vs the sector median at left
Optimi Health Corp.
Market Cap
$13.51M
Gross Margin
-486.44%
TTM Avg
120.99%
3Y Avg
51.45%
5Y Avg
35.54%
Market Cap
$13.66M
Gross Margin
64.68%
TTM Avg
63.93%
3Y Avg
63.08%
5Y Avg
61.52%
Market Cap
$13.74M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$13.92M
Gross Margin
-19.74%
TTM Avg
7.58%
3Y Avg
35.31%
5Y Avg
31.20%
Market Cap
$12.78M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$12.77M
Gross Margin
71.61%
TTM Avg
70.70%
3Y Avg
67.95%
5Y Avg
69.37%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Optimi Health Corp. (OPTH) | $13.51M | -486.44% | 120.99% | 51.45% | 35.54% |
| Vyome Holdings, Inc. (HIND)vs › | $13.66M | 64.68% | 63.93% | 63.08% | 61.52% |
| IN8bio, Inc. (INAB)vs › | $13.71M | 0.00% | 0.00% | 0.00% | 0.00% |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.74M | 0.00% | 0.00% | 0.00% | 0.00% |
| Passage Bio, Inc. (PASG)vs › | $13.24M | 0.00% | 0.00% | 0.00% | 0.00% |
| Sintx Technologies, Inc. (SINT)vs › | $13.92M | -19.74% | 7.58% | 35.31% | 31.20% |
| Obsidian Therapeutics Inc. (OBX)vs › | $14.17M | N/A | N/A | N/A | N/A |
| Cellectar Biosciences, Inc. (CLRB)vs › | $12.78M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cytosorbents Corporation (CTSO)vs › | $12.77M | 71.61% | 70.70% | 67.95% | 69.37% |
| Pulsenmore Ltd. Ordinary Shares (PLSM)vs › | $14.31M | 84.15% | 52.79% | 35.70% | 25.98% |
Gross Margin
-486.4%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | -302.64% |
| 2026-03-31 | 89.91% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 725.04% |
| 2025-06-30 | 92.64% |
| 2025-03-31 | 71.75% |
| 2024-12-31 | 73.15% |
| 2024-09-30 | -9.65% |
| 2024-06-30 | 49.93% |
| 2024-03-31 | -745.77% |
| 2023-12-31 | 167.62% |
| 2023-09-30 | 676.63% |
| 2023-06-30 | -72.29% |
| 2023-03-31 | 33.08% |
| 2022-12-31 | -29.85% |
| 2022-09-30 | -388.45% |
| 2022-06-30 | 21.28% |
| 2022-03-31 | 81.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-06-30 | 0.00% |
